OXURION announces its presence at SmallCap Paris this March 28, 2024 – 03/25/2024 at 7:00 p.m.

Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, Belgium, is pleased to announce its participation in the SmallCap Paris event, scheduled for March 28 in Paris.

This event, which takes place in key cities such as Paris, London, Frankfurt, Amsterdam, serves as a platform to connect European issuers with a broader network of institutional investors and family offices across Europe. .

Pascal Ghoson, CEO of Oxurion, expresses his enthusiasm: “Our participation in this event represents an opportunity. Indeed, for us it will be the ideal place to unveil our future growth strategy and to highlight the assets that make us unique.”

Find the full press release below:

Source link -86